Literature DB >> 23650109

Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia.

Aleksandra Ellert-Miklaszewska1, Michal Dabrowski, Maciej Lipko, Marcin Sliwa, Marta Maleszewska, Bozena Kaminska.   

Abstract

Microglia are myeloid cells residing in the central nervous system that participate in inflammatory responses and could promote injury and repair. Gliomas attract microglia and polarize them into tumor-supporting cells that participate in matrix remodeling, invasion, angiogenesis, and suppression of adaptive immunity. Although signaling pathways and critical regulators underlying classical inflammation are well established, signal transduction and transcriptional circuits underlying the alternative activation of microglia are poorly known. Using primary rat microglial cultures exposed to glioma conditioned medium or lipopolysaccharide (LPS), we demonstrate that microglia adapt different fates and polarize into pro-inflammatory or alternatively activated cells. Glioma-derived factors increased cell motility, phagocytosis, and sustained proliferation of microglial cells that was mediated by enhanced focal adhesion kinase and PI-3K/Akt signaling. The signals from glioma cells induced ERK and p38 MAPK but not JNK signaling and failed to activate pro-inflammatory Stat1 and NFκB signaling in microglial cells. Transcriptome analysis of microglial cultures at 6 h after exposure to glioma-conditioned medium or LPS revealed different patterns of gene expression. Glioma-induced activation was associated with induction of genes coding for ID (inhibitor of DNA binding) 1/3 and c-Myc, markers of the alternative phenotype Arg1, MT1-MMP, CXCL14, and numerous cytokines/chemokines implicated in immune cell trafficking. Many classical inflammation-related genes and signaling pathways failed to be induced. Our study indicates for the first time molecular pathways that direct microglia toward the pro-invasive, immunosuppressive phenotype.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23650109     DOI: 10.1002/glia.22510

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  43 in total

1.  TRAM1 Promotes Microglia M1 Polarization.

Authors:  Hanxiang Wang; Chun Liu; Ming Han; Chun Cheng; Dongmei Zhang
Journal:  J Mol Neurosci       Date:  2015-11-12       Impact factor: 3.444

2.  Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain.

Authors:  Kristan E van der Vos; Erik R Abels; Xuan Zhang; Charles Lai; Esteban Carrizosa; Derek Oakley; Shilpa Prabhakar; Osama Mardini; Matheus H W Crommentuijn; Johan Skog; Anna M Krichevsky; Anat Stemmer-Rachamimov; Thorsten R Mempel; Joseph El Khoury; Suzanne E Hickman; Xandra O Breakefield
Journal:  Neuro Oncol       Date:  2015-10-03       Impact factor: 12.300

3.  Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma.

Authors:  Susan Brandenburg; Kati Turkowski; Annett Mueller; Yordan T Radev; Sabine Seidlitz; Peter Vajkoczy
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

4.  Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.

Authors:  Jiping Wang; Jianmei W Leavenworth; Anita B Hjelmeland; Reed Smith; Neha Patel; Ben Borg; Ying Si; Peter H King
Journal:  Glia       Date:  2019-08-10       Impact factor: 7.452

5.  Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.

Authors:  Konrad Gabrusiewicz; Benjamin Rodriguez; Jun Wei; Yuuri Hashimoto; Luke M Healy; Sourindra N Maiti; Ginu Thomas; Shouhao Zhou; Qianghu Wang; Ahmed Elakkad; Brandon D Liebelt; Nasser K Yaghi; Ravesanker Ezhilarasan; Neal Huang; Jeffrey S Weinberg; Sujit S Prabhu; Ganesh Rao; Raymond Sawaya; Lauren A Langford; Janet M Bruner; Gregory N Fuller; Amit Bar-Or; Wei Li; Rivka R Colen; Michael A Curran; Krishna P Bhat; Jack P Antel; Laurence J Cooper; Erik P Sulman; Amy B Heimberger
Journal:  JCI Insight       Date:  2016-02-25

6.  Rho-Associated Kinase Inhibitors Promote Microglial Uptake Via the ERK Signaling Pathway.

Authors:  Peicai Fu; Ronghua Tang; Zhiyuan Yu; Caihong Li; Xue Chen; Minjie Xie; Wei Wang; Xiang Luo
Journal:  Neurosci Bull       Date:  2016-01-18       Impact factor: 5.203

Review 7.  Circulating biomarkers for gliomas.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

8.  Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.

Authors:  Omar Dzaye; Feng Hu; Katja Derkow; Verena Haage; Philipp Euskirchen; Christoph Harms; Seija Lehnardt; Michael Synowitz; Susanne A Wolf; Helmut Kettenmann
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-30       Impact factor: 3.685

9.  Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.

Authors:  A Ellert-Miklaszewska; P Wisniewski; M Kijewska; P Gajdanowicz; D Pszczolkowska; P Przanowski; M Dabrowski; M Maleszewska; B Kaminska
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

Review 10.  The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease.

Authors:  Shih-Ying Wu; Kounosuke Watabe
Journal:  Front Biosci (Landmark Ed)       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.